ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced its adoptive cell therapy, ELIAS Cancer Immunotherapy (ECI®), has received full approval from the U.S.

Sophie Fulton was diagnosed with a rare bone cancer last year, and after losing part of her leg is now struggling with living ...

A devastated family are being forced to leave their home of 12 years after their daughter was diagnosed with rare bone cancer ...

OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that Paul Romness, CEO, and ...

is indicated for the treatment of canine osteosarcoma, a deadly form of bone cancer. Large and giant breed dogs, such as Golden Retrievers, Boxers, Greyhounds, Labradors and German Shepherds ...

ELIAS Animal Health, a companion animal cancer therapeutics company, shared today that the USDA Center for Veterinary Biologics (USDA CVB) issued a full approval for its ELIAS Cancer Immunotherapy ...

President Donald Trump has signed an executive order designating English the official language of the country, the first time ...

Vets removed nine-year-old Calvin’s scapula — his shoulder blade —along with all traces of his tumor while keeping his leg ...

The University of Rochester’s Wilmot Cancer Institute has been designated as a National Cancer Institute. The prestigious ...

Puppies initially need a full series of shots, but once grown, they may not need boosters as often as is typically recommended.